S736 Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease: Results From a Randomized Phase 3 U-EXCEL Study. (October 2022) - Colombel, Jean-Frederic; Lacerda, Ana Paula; Peyrin-Biroulet, Laurent; D'Haens, Geert; Panaccione, Remo; Reinisch, Walter; Louis, Edouard; Chen, Minhu; Nakase, Hiroshi; Greenbloom, Susan; DuVall, George; Sanchez-Gonzalez, Yuri; et al.